NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Yesterday, at the 2010 Rodman & Renshaw Global Healthcare Conference at the NY Palace Hotel in New York City, Chairman/CEO Thomas A. Moore of Advaxis, Inc., (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, outlined the company’s corporate strategy in a new company presentation.
